How Oura Just Scored an $11 Billion Valuation
Oura's funding supports growth driven by strong sales, new product features including blood testing, and partnerships to enhance health monitoring technology.
- Oura, the Finnish health tech company, said Tuesday it raised over $900 million in a Series E funding round, valuing the company at $11 billion.
- After posting rapid revenue growth, Oura more than doubled revenue to $500 million in 2024 and plans to use new funding for AI, production innovation, new health features and global distribution.
- Earlier this month, Oura launched the Health Panels feature, allowing users to book a $99 blood test at Quest Diagnostics labs and view results in the app with AI summaries.
- Led by Fidelity Management & Research Company, the round included ICONIQ, Whale Rock, and Atreides; CEO Tom Hale said the investment will accelerate innovation and expand global reach.
- Oura plans expansion in 20 countries and employs about 1,000 people globally while holding more than 80% of the smart ring market after selling over 5.5 million rings.
18 Articles
18 Articles
Oura raises $900 million in funding at $11 billion Valuation to become the Apple of preventive health - Tech Startups
ŌURA, the Finnish health tech startup best known for its Oura Ring, has raised more than $900 million in new funding at an $11 billion valuation — a staggering leap for a hardware company once dismissed as niche. The round, […] The post Oura raises $900 million in funding at $11 billion Valuation to become the Apple of preventive health first appeared on Tech Startups.
"With this investment, we will accelerate innovation, expand our global reach, and set a new standard for what wearables can achieve in promoting preventive health," CEO Tom Hale said in a statement.
Coverage Details
Bias Distribution
- 83% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium